Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NextEra Energy, Inc. (NEE) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

NextEra Energy, Inc.Trade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

NextEra Energy, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? NextEra Energy, Inc. trades at $79.08 (market cap $163.48B), while Vir Biotechnology Inc. Common Stock trades at $10.51 (market cap $1.76B). The key difference: NextEra Energy, Inc. is far larger — about 92.9× Vir Biotechnology Inc. Common Stock's market cap, and NextEra Energy, Inc. pays a 3.18% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NextEra Energy, Inc. for 83 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

NEEVIR
Market Cap
$163.48B$1.76B
Volume
11,050,0362,764,948
Sector
UtilitiesHealth
52-Week High
$97.88$11.78
52-Week Low
$75.49$5.12
Typical Hold Time
83 Days0 Days
Enterprise Value
$270.81B$1.32B
Dividend Yield
3.18%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NextEra Energy, Inc.

NextEra Energy (NEE) trades at $78.22, down 0.37% on the day, with a bullish technical signal but mixed momentum indicators. The company reported strong earnings beats in Q1 and Q2 2026, with revenue of $27.41B in 2025 and a net income margin of 32.4%. Recent news highlights growth initiatives, including a $22.3B energy infrastructure project in Texas. The stock is supported by a consensus price target of $95.60, implying significant upside from current levels.

NEE presents a favorable investment case driven by robust profitability, strategic expansion in clean energy, and strong analyst support. However, risks include rising debt levels, with debt-to-asset ratio increasing to 47.6% in 2025, and sensitivity to interest rate changes. The stock's current valuation metrics, such as a P/E of 17.61, appear reasonable relative to growth prospects, but investors should monitor execution on large-scale projects and regulatory developments.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEE
100% Buy0% Sell
Avg holding period · 83 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About NextEra Energy, Inc.

NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.

Read more on NEE →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →